Proteome to Analyze Cancer Antibodies for Onconome | GenomeWeb
NEW YORK (GenomeWeb News) — Proteome Sciences said today it will use its ProteoShop services to analyze diagnostic antibodies related to prostate and colon cancer for Onconome.
 
Under the agreement, Proteome Sciences will use its 2-D gel Western blotting technology to characterize Onconome’s antibodies, and will use its 2-D gel electrophoresis and Tandem Mass Tags for further analysis.  
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.